Progress of induced pluripotent stem cells in ophthalmic diseases
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Induced pluripotent stem cells(iPSCs)are reprogrammed through transduction of exogenous transcription factors, into somatic cells, reprogramming the somatic cells to embryonic stem cells-like cells with potencies of unlimited proliferation and pluripotent differentiation. This technology is a milestone in the field of regenerative medicine, and many related studies have been made these years. In the development of iPSCs technology, we have achieved a lot of progress; these will lay a foundation of cell therapy. Meanwhile, the successfully reprogrammed human somatic stem cells and good results in the study of animal models have been achieved. This article aims to emphasize the development of iPSCs in Ophthalmology.

    Reference
    Related
    Cited by
Get Citation

Jia-Hui Wu, Hong-Ping Cui. Progress of induced pluripotent stem cells in ophthalmic diseases. Guoji Yanke Zazhi( Int Eye Sci) 2013;13(2):295-298

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:October 14,2012
  • Revised:January 06,2013
  • Adopted:
  • Online:
  • Published: